28 participants
Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-28
- Start Date:
- 2024-10-22
- Completion:
- 2029-06-30
Conditions
- T-ALL
Interventions
- DRUG
No Results Yet